Lv01
0 积分 2025-06-10 加入
Optimising treatment in Crohn's disease: is the main issue early versus late or biologic naive versus biologic experienced?
1小时前
求助中
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
2小时前
已完结
Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
3个月前
已完结
[Recommendations for diagnosis and treatment of psoriatic arthritis in China]
5个月前
已完结
Glucagon-Like Peptide 1 Receptor Agonists in Patients With Inflammatory Arthritis or Psoriasis
5个月前
已完结
Reply: Tofacitinib is a step forward for management of patients with interstitial lung disease associated with anti-MDA5-positive dermatomyositis
6个月前
已关闭
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A (LY3509754): A Phase I Randomized Placebo‐Controlled Study
6个月前
已完结
皖公网安备34019202002308
